{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T05:05:04Z","timestamp":1789621504331,"version":"build-2803163510"},"reference-count":15,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Lacrimal gland adenoid cystic carcinoma (LGACC) is a rare, aggressive malignancy with limited epidemiological data, particularly from East Asian populations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective single-center series describes the clinicopathological features, treatment patterns, and outcomes of six consecutive patients with pathologically confirmed LGACC treated at the Cancer Hospital, Chinese Academy of Medical Sciences between 2012 and 2024. Findings were placed in the context of 22 cases extracted from the SEER database (ICD-O-3 histology code 8200\/3, primary site C69.6). Survival was estimated for the institutional cohort and, descriptively, for a combined regional-stage cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The median age at diagnosis was 31 years (range 26\u201359), with equal sex distribution. All tumors were regional-stage, and 66.7% were T3\u20134. All patients underwent surgery (orbital exenteration in 66.7%, globe-sparing resection in 33.3%; R0 margins in 33.3%) followed by high-dose conformal radiotherapy (66\u201370 Gy). One disease-related death occurred. Five-year overall survival (OS) and disease-specific survival (DSS) were both 75% (95% CI 42.6\u2013100%). Local recurrence was observed in 16.7% and distant metastases in 50%. Treatment-related toxicity was mostly grade I\u2013II. In a combined regional-stage cohort of 17 patients, surgery plus radiotherapy was associated with numerically higher 5-year OS (64.8% versus 26.7%) and DSS (74.1% versus 26.7%) compared with surgery or radiotherapy alone; these estimates are presented only for descriptive context and are limited by small numbers and wide confidence intervals. A sensitivity analysis excluding two SEER patients with unknown surgery status who received radiotherapy alone yielded consistent numerical trends. Chemotherapy was not used as primary or adjuvant therapy for the initial disease; it was given concurrently with radiotherapy for early postoperative residual disease in one patient and after delayed local recurrence in another.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>In this series of predominantly advanced LGACC, surgery followed by adjuvant high-dose conformal radiotherapy achieved favorable local control with predominantly mild toxicity. Combined SEER comparisons should be interpreted cautiously because of the small sample size.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1900973","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T04:49:10Z","timestamp":1789620550000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical characteristics, management, and outcomes of lacrimal gland adenoid cystic carcinoma: a single-center series with contextual comparison to SEER data"],"prefix":"10.3389","volume":"16","author":[{"given":"Yongbo","family":"Xiang","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Oncology, Qingdao Central Hospital, University of Health and Rehabilitation Sciences (Qingdao Central Hospital)","place":["Qingdao, China"]},{"name":"Qingdao Medical College, Qingdao University","place":["Qingdao, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingming","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoshuai","family":"Bai","sequence":"additional","affiliation":[{"name":"Department of Emergency Internal Medicine, the Affiliated Hospital of Qingdao University","place":["Qingdao, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junlin","family":"Yi","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwei","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Qu","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuesong","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runye","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinbo","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3211","DOI":"10.3390\/cancers15123211","article-title":"Spatial transcriptomics identifies expression signatures specific to lacrimal gland adenoid cystic carcinoma cells","volume":"15","author":"Moeyersoms","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B2","doi-asserted-by":"publisher","first-page":"13755","DOI":"10.3390\/ijms241813755","article-title":"A review of the molecular landscape of adenoid cystic carcinoma of the lacrimal gland","volume":"24","author":"Powell","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00135","article-title":"Adenoid cystic carcinoma of the lacrimal gland: High dose adjuvant proton therapy to improve patients outcomes","volume":"10","author":"Lesueur","year":"2020","journal-title":"Front Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijom.2011.02.010","article-title":"Outcomes of patients with adenoid cystic carcinoma of the minor salivary glands","volume":"40","author":"DeAngelis","year":"2011","journal-title":"Int J Oral Maxillofac Surg"},{"key":"B5","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1177\/03008916211070328","article-title":"Differences in clinical features and prognosis between orbit adenoid cystic carcinoma and adenocarcinoma: A study from the Seer 18 database","volume":"109","author":"Liu","year":"2023","journal-title":"Tumori"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.65.11.4","article-title":"Prognostic impact of Notch1 intracellular domain, P63, and C-Myc in lacrimal gland adenoid cystic carcinoma","volume":"65","author":"Zhao","year":"2024","journal-title":"Invest ophth Vis Sci"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.6831","article-title":"Incidence, clinical features, and survival outcomes of primary Malignant lacrimal gland tumors: A population-based analysis","volume":"13","author":"He","year":"2024","journal-title":"Cancer Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-023-05224-w","article-title":"Epidemiology of and factors associated with overall survival for patients with head and neck adenoid cystic carcinoma","volume":"149","author":"He","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.27408","article-title":"Adenoid cystic carcinoma of the head and neck: Incidence and survival trends based on 1973-2007 Surveillance, Epidemiology, and End Results data","volume":"118","author":"Ellington","year":"2012","journal-title":"Cancer"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.18240\/ijo.2024.08.06","article-title":"Prognostic factors for lacrimal gland adenoid cystic carcinoma: A retrospective study in Chinese patients","volume":"17","author":"Yang","year":"2024","journal-title":"Int J Ophthalmol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.3707","article-title":"Multicentre clinicopathological study of adenoid cystic carcinoma: A report of 296 cases","volume":"10","author":"Huang","year":"2021","journal-title":"Cancer Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.18240\/ijo.2024.01.22","article-title":"Treatment of lacrimal gland adenoid cystic carcinoma: A systematic review and meta-analysis","volume":"17","author":"Yan","year":"2024","journal-title":"Int J Ophthalmol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2009.07.1753","article-title":"Radiation dose-volume effects of optic nerves and chiasm","volume":"76","author":"Mayo","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2011.05.026","article-title":"Severe dry eye syndrome after radiotherapy for head-and-neck tumors","volume":"82","author":"Bhandare","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyad346","article-title":"Neoadjuvant intra-arterial cytoreductive chemotherapy improves outcomes in lacrimal gland adenoid cystic carcinoma","volume":"29","author":"Costa","year":"2024","journal-title":"Oncologist"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1900973\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T04:49:20Z","timestamp":1789620560000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1900973\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,17]]},"references-count":15,"alternative-id":["10.3389\/fonc.2026.1900973"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1900973","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,17]]},"article-number":"1900973"}}